Anika Therapeutics ANIK
NASDAQ ANIK
$19.10 -0.26 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anika Therapeutics (ANIK) Selling, General & Administrative (2010 - 2026)

Updated

Anika Therapeutics (ANIK) reported Selling, General & Administrative of $10.95 million for Q2 2026, down 10.5% from $12.23 million a year earlier and down 38.4% from the prior quarter.

Analysis

Anika Therapeutics (ANIK) Selling, General & Administrative (2010 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Anika Therapeutics' Selling, General & Administrative came in at $52.67 million, up 5.3% year-over-year; for FY2025, it was $49.09 million, down 11.6% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of -4.0% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $55.56 million in FY2024 (-7.3%), $59.93 million in FY2023 (+17.0%), $51.23 million in FY2022 (-30.9%) and $74.1 million in FY2021 (+23.4%).
  • The Q2 2026 figure ranks as the lowest quarterly Selling, General & Administrative since Q4 2023.
  • Year over year, Selling, General & Administrative gained in two of the last seven quarters, with an average decline of 8.6%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q1 2023 (growth of 40.6%); the low point was Q3 2024 (a decline of 45.5%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $17.77 million (Q1 2026), $12.08 million (Q4 2025) and $11.87 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 2.33 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 4.03 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 2.07 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 617.90 Mn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 3.20 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 2.23 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 1.80 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 561.20 Mn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 1.26 Bn
10 Anika Therapeutics 255.62 Mn -10.93 Mn 21.24 Mn 10.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.95 Mn
Mar 31, 2026 17.77 Mn
Dec 31, 2025 12.08 Mn
Sep 30, 2025 11.87 Mn
Jun 30, 2025 12.23 Mn
Mar 31, 2025 12.91 Mn
Dec 31, 2024 11.32 Mn
Sep 30, 2024 13.54 Mn
Jun 30, 2024 15.62 Mn
Mar 31, 2024 15.07 Mn
Dec 31, 2023 -15.59 Mn
Sep 30, 2023 24.83 Mn
Jun 30, 2023 23.69 Mn
Mar 31, 2023 27.00 Mn
Dec 31, 2022 -10.52 Mn
Sep 30, 2022 21.28 Mn
Jun 30, 2022 21.27 Mn
Mar 31, 2022 19.20 Mn
Dec 31, 2021 20.43 Mn
Sep 30, 2021 17.50 Mn
API Access

Anika Therapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ANIK&period=max&api_key=YOUR_API_KEY